Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Phase II trial of caracemide (NSC 253272) in advanced unresectable non-small cell bronchogenic carcinoma. An Illinois Cancer Council study.

× No keyword cloud information.

3 in total

1. Phase II study of caracemide in advanced or recurrent non-small cell lung cancer.

Authors: C P Belani; M Eisenberger; D Van Echo; D Hiponia; J Aisner
Journal: Cancer Treat Rep Date: 1987-11

2. Phase I trial of caracemide using bolus and infusion schedules.

Authors: M N Raber; F Adams; J Kavanagh; S Legha; I Dimery; I Krakoff
Journal: Cancer Treat Rep Date: 1987-04

3. Inhibition of ribonucleotide reductase by caracemide.

Authors: E C Moore; T L Loo
Journal: Cancer Treat Rep Date: 1984-10

3 in total

4 in total

1. A phase II trial of homoharringtonine and caracemide in the treatment of patients with advanced large bowel cancer.

Authors: R S Witte; S Lipsitz; T L Goodman; R F Asbury; G Wilding; C M Strnad; T J Smith; D G Haller
Journal: Invest New Drugs Date: 1999 Impact factor: 3.850

2. A phase II trial of amonafide, caracemide, and homoharringtonine in the treatment of patients with advanced renal cell cancer.

Authors: R S Witte; P Hsieh; P Elson; M M Oken; D L Trump
Journal: Invest New Drugs Date: 1996 Impact factor: 3.850

Review 3. Inhibitors of the Cancer Target Ribonucleotide Reductase, Past and Present.

Authors: Sarah E Huff; Jordan M Winter; Chris G Dealwis
Journal: Biomolecules Date: 2022-06-10

Review 4. Clinical pharmacology and clinical trials of ribonucleotide reductase inhibitors: is it a viable cancer therapy?

Authors: Mukundan Baskar Mannargudi; Subrata Deb
Journal: J Cancer Res Clin Oncol Date: 2017-06-17 Impact factor: 4.322

4 in total